Brainsway Ownership
| BWAY Stock | USD 11.88 0.22 1.82% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 38.7 M | Current Value 18.4 M | Avarage Shares Outstanding 11.1 M | Quarterly Volatility 5.7 M |
Brainsway | Build AI portfolio with Brainsway Stock |
Brainsway Stock Ownership Analysis
About 32.0% of the company shares are held by institutions such as insurance companies. The book value of Brainsway was currently reported as 1.73. The company had not issued any dividends in recent years. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 118 people. For more info on Brainsway please contact Christopher Jako at 972 2 582 4030 or go to https://www.brainsway.com.Besides selling stocks to institutional investors, Brainsway also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Brainsway's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Brainsway's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Brainsway Quarterly Liabilities And Stockholders Equity |
|
About 6.0% of Brainsway are currently held by insiders. Unlike Brainsway's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Brainsway's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Brainsway's insider trades
Brainsway Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Brainsway is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainsway backward and forwards among themselves. Brainsway's institutional investor refers to the entity that pools money to purchase Brainsway's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2025-03-31 | 90.3 K | Legato Capital Management Llc | 2025-03-31 | 89.4 K | Two Sigma Advisers, Llc | 2025-03-31 | 80.5 K | Marshall Wace Asset Management Ltd | 2025-03-31 | 78.4 K | Huntleigh Advisors Inc | 2025-03-31 | 73.3 K | Zuckerman Investment Group, Llc | 2025-03-31 | 67 K | Eagle Global Advisors, Llc | 2025-06-30 | 62.3 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 30.3 K | Ubs Group Ag | 2025-03-31 | 28.1 K | Valor Management Llc | 2025-03-31 | 2.1 M | Masters Capital Management Llc | 2025-03-31 | 1000 K |
Brainsway Outstanding Bonds
Brainsway issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brainsway uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brainsway bonds can be classified according to their maturity, which is the date when Brainsway has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Brainsway Corporate Filings
| 1st of July 2025 Other Reports | ViewVerify | |
6K | 11th of June 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 1st of May 2025 Other Reports | ViewVerify | |
| 22nd of April 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Brainsway Stock Analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.